Bloodbuy Advances as Semi-Finalist in Harvard Health Acceleration Challenge
Making Elite Shortlist of 18 Top Innovations, Narrowed Down From 478 Entries
DALLAS (October 28, 2014) – BloodSolutions, LLC, a portfolio company of Dallas-based private equity firm HealthCap Partners, LLC, recently developed and deployed it’s Bloodbuy technology platform, an innovative cloud-based platform designed to address the uneven geographic distribution of available blood supply in the U.S., in real-time.
Bloodbuy has been recognized by the Forum on Healthcare Innovation, a collaboration between Harvard Business School (HBS) and Harvard Medical School (HMS) as one of eighteen proven innovations with the ability to improve quality, reduce costs, and, ultimately, increase value in the health care industry. The Forum on Healthcare Innovation has established the Harvard Health Acceleration Challenge with the goal of identifying and promoting demonstrated health care innovations that are ready to scale, such as Bloodbuy.
Harvard received 478 entries from 29 countries, including submissions from such industry-leading organizations as Mayo Clinic, Cleveland Clinic, MD Anderson, Kaiser Permanente, and Intermountain Healthcare. In addition to these premiere provider organizations, innovations were submitted by numerous startups and thought-leading institutions, including Stanford University, Yale School of Public Health and Harvard, among many others.
Bloodbuy has advanced from the field of 478, to the elite semi-finalist pool of 18 proven innovations with the potential to have a massive positive impact on the healthcare industry once disseminated on a large scale.
“We are excited an honored to have received this recognition from the Forum on Healthcare Innovation and we are eager work with them in an effort to get our Bloodbuy technology in the hands of organizations who need it the most,” said Chris Godfrey, Founder & CEO of Bloodbuy. “Our cloud-based platform enables blood centers to identify and connect directly with hospitals many miles away, with the goal of supplying lifesaving blood products that may be depleted in that hospitals particular geography; for whatever reason, may it be weather-driven or otherwise. We’re leveraging advanced technology to address the uneven distribution of available resources in real-time.”